| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 24, 2026 | ±5.0% | -1.8% | over-priced |
| July 29, 2025 | ±4.7% | +1.1% | over-priced |
| April 24, 2025 | ±4.0% | +6.6% | under-priced |
| October 23, 2024 | ±2.1% | +4.0% | under-priced |
| July 24, 2024 | ±3.4% | -0.0% | over-priced |
| April 24, 2024 | ±2.6% | +5.6% | under-priced |
| October 25, 2023 | ±1.9% | -3.5% | under-priced |
| July 26, 2023 | ±2.0% | -5.4% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.68 | $4.8B | $1.5B |
| Q4 FY2025 | — | $0 | $0 |
| Q2 FY2025 | $1.41 | $4.4B | $1.3B |
| Q1 FY2025 | $1.28 | $4.1B | $1.2B |
Texas Instruments Incorporated (TXN) reports in 109 days, with the next report estimated for September 30, 2026. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 3.5% on average — the market has been roughly fair on TXN's earnings risk. Fundamentals into the print: EPS up 14.3% year-over-year, revenue up 16.2%. QuantLogix's live 5-factor engine currently reads TXN as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →